Details for Patent: 11,931,455
Which drugs does patent 11,931,455 protect, and when does it expire?
Patent 11,931,455 protects MYHIBBIN and is included in one NDA.
This patent has four patent family members in three countries.
Summary for Patent: 11,931,455
| Title: | Pharmaceutical suspension for oral dosage |
| Abstract: | Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the active pharmaceutical ingredient is selected from quetiapine, sildenafil, tadalafil, cinacalcet, ticagrelor, mycophenolate, aprepitant, zonisamide, and primidone. |
| Inventor(s): | Sandip Mehta, Manish Kumar Umrethia, Jayanta Mandal |
| Assignee: | Liqmeds Worldwide Ltd |
| Application Number: | US18/362,179 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 11,931,455
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | MYHIBBIN | mycophenolate mofetil | SUSPENSION;ORAL | 216482-001 | May 1, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | PROPHYLAXIS OF ORGAN REJECTION | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,931,455
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3836898 | ⤷ Start Trial | |||
| United Kingdom | 202103764 | ⤷ Start Trial | |||
| United Kingdom | 2591396 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
